Sub-Total: $0.00 CAD
Cartalax 20mg
$65.00 CAD
Cartalax is a peptide that supports cartilage and connective-tissue research by helping investigators explore whether the AED sequence can encourage aging stem cells to activate cartilage-forming pathways and produce proteins involved in cartilage structure and resilience.
Researchers study Cartalax to see whether it can help older cells switch on the building blocks used to form and maintain cartilage.
Description
Cartalax is a short tripeptide studied for its effects on chondrogenic differentiation and cartilage-associated signaling. In aging human mesenchymal stem-cell cultures, the AED peptide has been investigated for its influence on the expression and production of SOX9, aggrecan, type II collagen, and cartilage oligomeric matrix protein—key markers involved in cartilage formation and extracellular-matrix structure.
Products supplied by Sentient Biogenix are intended solely for non-clinical laboratory research by qualified personnel in appropriate facilities.These compounds are not approved for human or animal consumption, and are not intended for diagnostic, therapeutic, or clinical use.
What others are saying
There are no contributions yet.